Press Releases

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced that it has signed an agreement for Probuphine (buprenorphine) implant to be included on the Federal Supply Schedule ("FSS"), providing U.S. veterans and other federal government agencies with access to Titan's novel 6-month maintenance treatment for

SUNNYVALE, Calif., Jan. 13, 2020 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) will be discussing its business and revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare Conference on Wednesday, January 15, 2020 at 10:00 am PACIFIC /

BERKELEY, Calif., Jan. 13, 2020 /PRNewswire/ -- Fauna Bio, developers of the largest and most accurately characterized hibernation biobank coupled with next-generation sequencing, announced today

SOUTH PLAINFIELD, N.J., Jan. 13, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today is providing a corporate update that will be presented at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15th at 8:30 a.m. PST. Stuart W. P

SANTA CRUZ, Calif., Jan. 13, 2020 /PRNewswire/ -- Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced an expanded Genome Assembly offering through its best-in-class genome assembly services, leveraging its Omni-C Technology, which provides unparalleled uniformity per-base genome coverage. The new offering expands the m

BOSTON, Jan. 13, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced a regulatory update following the completion of a scientific advice meeting with the Medicines and Healthcare Products Regu

CAMBRIDGE, Mass., Jan. 13, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced corporate goals for 2020, which provide a path to achieve the company's "2020 Blueprint" strategy for launching its global commercial business.

WAKEFIELD, Mass., Jan. 13, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced its management will attend the following institutional investor conferences in January 2020:

LEXINGTON, Mass. and NEW YORK, Jan. 13, 2020 /PRNewswire/ -- Curis, Inc (NASDAQ: CRIS) and DarwinHealth, Inc. today announced a multi-year scientific research collaboration to use quantitative, systems biology-based algorithms, CLIA-approved technologies, and novel, validated approaches focused on Master Regulator (MR) protein

LEBANON, N.H., Jan. 13, 2020 /PRNewswire/ -- Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan.  Under the terms of the agreement, Avitide will use its proprietary affinity chromatography discovery, development, and supply platform for programs defined by All